Brind.

Rain Foundation is overseeing protocol development and has made a strategic commitment to the prediction markets sector, involving Company and Enlivex.

2 reports, 2 independent Updated May 28

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 2
Developments: 2
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Rain Foundation is overseeing protocol development and has made a strategic commitment to the prediction markets sector, involving Company and Enlivex.

Who's involved

What this event is mainly about

rain Enlivex Company

How it developed

Newest first. Tap a step to see who reported it.

Jun 7Enlivex is a company based in Nes-Ziona, Israel.Sub-event
May 28Rain Foundation focuses on protocol development and strategic commitment to prediction markets.1 source
- manilatimes.net

Keep exploring

The entities involved

rain
Canadian Counter-Strike: Global Offensive player

Nothing else this week.
Enlivex
Israeli drug company, focused on Cell Immunotherapy

Nothing else this week.
Company
Direct Mail Division of FSSI
- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Mon 13:17
- A partnership with BARDA has accelerated the development of SCY-247 for the company.Mon 13:17

Coverage

Newest first; wire copies grouped

May 28manilatimes.net
Aug 18GlobeNewswireEnlivex Announces Positive Topline Data From Multi-Country, Randomized, Controlled, Phase I/II Trial Evaluating Allocetra in Patients With Moderate-To-Severe Knee Osteoarthritis ENX-CL-05-001 Trial: